Can Bill Gruber Take Solace Where He Took Interlace? from Medtech Talk

Can Bill Gruber Take Solace Where He Took Interlace?

34 minutes Posted Jul 2, 2015 at 4:00 am.

0:00

34:05

Share at current time

Show notes

Solace Therapeutics CEO Bill Gruber hopes to repeat the successful exit he helped execute when Hologic paid close to $300 million for his previous company Interlace.

← See all 207 episodes of Medtech Talk